pmc logo imageJournal ListSearchpmc logo image
Logo of neuroncolJournal URL: redirect3.cgi?&&auth=0poCvMrwXKPAQO0pC3xQe-Xhbt5K1M-UBRPv_5Qih&reftype=publisher&issue-id=145975&journal-id=310&FROM=TOC|Banner&TO=Publisher|Other|N%2FA&rendering-type=normal&&http://www.dukeupress.edu/neuro-oncology/
Other Issues:  previous | next | latest | archive
Volume 3(4);  October 2001
Research Articles
Ex vivo pediatric brain tumors express Fas (CD95) and FasL (CD95L) and are resistant to apoptosis induction.
C. D. Riffkin, A. Z. Gray, C. J. Hawkins, C. W. Chow, and D. M. Ashley
Neuro Oncol. 2001 October; 3(4): 229–240.
PMCID: PMC1920621
Levels of N7-(2-hydroxyethyl)guanine as a molecular dosimeter of drug delivery to human brain tumors.
W. J. Bodell, D. D. Giannini, S. Hassenbusch, and V. A. Levin
Neuro Oncol. 2001 October; 3(4): 241–245.
PMCID: PMC1920624
Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas.
S. Gururangan, L. Cokgor, J. N. Rich, S. Edwards, M. L. Affronti, J. A. Quinn, J. E. Herndon, 2nd, J. M. Provenzale, R. E. McLendon, S. Tourt-Uhlig, J. H. Sampson, V. Stafford-Fox, S. Zaknoen, M. Early, A. H. Friedman, and H. S. Friedman
Neuro Oncol. 2001 October; 3(4): 246–250.
PMCID: PMC1920622
Carboplatin chemotherapy for progressive intramedullary spinal cord low-grade gliomas in children: three case studies and a review of the literature.
T. E. Hassall, A. E. Mitchell, and D. M. Ashley
Neuro Oncol. 2001 October; 3(4): 251–257.
PMCID: PMC1920625
Immunotherapy Task Force for malignant brain tumors. April 21, 2001, Toronto, Ontario.
R. P. Glick and T. Lichtor
Neuro Oncol. 2001 October; 3(4): 258–264.
PMCID: PMC1920623
Other Issues:  previous | next | latest | archive
Articles from Neuro-Oncology are provided here courtesy of
Society for Neuro-Oncology and Duke University Press